BHST vs BLNE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BHST Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioHarvest Sciences Inc. Common Stock (BHST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BLNE counters with relative strength in Valuation. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus BLNE at 5.5x Forward P/E and -179.8% operating margin (+29.8% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BLNE sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BHST Revenue | BLNE Revenue | BHST Op. Margin | BLNE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $10M | N/A | -114.7% | BLNE |
| FY2019 | N/A | $10M | N/A | -81.6% | BLNE |
| FY2020 | N/A | $10M | N/A | -55.4% | BLNE |
| FY2021 | N/A | $10M | N/A | -55.7% | BLNE |
| FY2022 | N/A | $10M | N/A | -47.9% | BLNE |
| FY2023 | $10M | $10M | -78.6% | -23.1% | BLNE |
| FY2024 | $30M | $0M | -27.7% | -467.0% | BHST |
| FY2025 | $30M | $10M | -16.2% | -251.5% | BHST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHST | BLNE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $13.1M | Larger Scale | BHST |
| Trailing P/E Ratio Valuation | N/M | 5.5x | Lower Multiple | BLNE |
| Forward P/E Ratio Valuation | N/M | 5.5x | Lower Multiple | BLNE |
| Revenue Growth (YoY) Growth | +3.8% | +29.8% | Higher Growth | BLNE |
| Operating Margin (TTM) Profitability | -18.0% | -179.8% | Higher Margin | BHST |
| Net Profit Margin Profitability | -31.2% | -185.9% | Higher Margin | BHST |
| Return on Equity (ROE) Capital Efficiency | -142.5% | -42.4% | Higher ROE | BLNE |
| 52-Week Range Position Momentum | 6% ($1โ$7) | 0% ($0โ$4) | Stronger Trend | BHST |
| Beta / 30D Volatility Risk Regime | 0.25ฮฒ ยท 86% Vol | 2.74ฮฒ ยท 123% Vol | Lower Realized Risk | BHST |
| Unified Institutional Score Composite Signal | 58.2 / 100 (HOLD) | 43.4 / 100 (HOLD) | Higher Composite | BHST |